(1E,4E)-1-(1-(Pentan-2-yl)-1H-benzo[d]imidazole-2-yl)-5-(1-(pentan-2-yl)-1H-imidazole-2-yl)penta-1,4-dien-3-one

ID: ALA4205744

PubChem CID: 145977872

Max Phase: Preclinical

Molecular Formula: C25H32N4O

Molecular Weight: 404.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC(C)n1ccnc1/C=C/C(=O)/C=C/c1nc2ccccc2n1C(C)CCC

Standard InChI:  InChI=1S/C25H32N4O/c1-5-9-19(3)28-18-17-26-24(28)15-13-21(30)14-16-25-27-22-11-7-8-12-23(22)29(25)20(4)10-6-2/h7-8,11-20H,5-6,9-10H2,1-4H3/b15-13+,16-14+

Standard InChI Key:  VMTBVKUNTWYHGV-WXUKJITCSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
   12.8825  -13.1371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4700  -12.4226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6450  -12.4226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2325  -11.7082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6450  -10.9937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2325  -13.1371    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2325  -10.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4120  -10.1930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.2405   -9.3860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9550   -8.9735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5681   -9.5256    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9271   -9.9671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3751   -9.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6300   -8.5694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4370   -8.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6919   -7.6133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7075  -13.1371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1924  -13.8045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9771  -13.5496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9771  -12.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1924  -12.4697    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6915  -12.3121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4060  -12.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4060  -13.5496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6915  -13.9621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1305  -14.7607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9375  -14.5892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4895  -15.2023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2346  -15.9869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7866  -16.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  3  6  2  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  7 11  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 11 13  1  0
  5  7  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 17 21  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 19 25  2  0
 20 22  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 18 27  1  0
  1 17  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4205744

    ---

Associated Targets(Human)

PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PWR-1E (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 404.56Molecular Weight (Monoisotopic): 404.2576AlogP: 6.25#Rotatable Bonds: 10
Polar Surface Area: 52.71Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.03CX LogP: 6.37CX LogD: 6.36
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.38Np Likeness Score: -0.66

References

1. Zhang X, Guo S, Chen C, Perez GR, Zhang C, Patanapongpibul M, Subrahmanyam N, Wang R, Keith J, Chen G, Dong Y, Zhang Q, Zhong Q, Zheng S, Wang G, Chen QH..  (2017)  Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.,  137  [PMID:28601720] [10.1016/j.ejmech.2017.05.062]

Source